$BMY 4/A SEC Filings

Filed On	Filing
09 Apr 2020	Form 4/A: Mily Elizabeth, EVP, Strategy & BD Granted 14,649 Market Share Units · Granted 21,973 Performance Shares
12 Mar 2020	Form 4/A: Eid Joseph, SVP,Head Glob. Medical Affairs Received 2,825 shares by exercise or conversion · Gave up 968 shares to cover exercise price or tax ($55.1K) · Acquired 2,825 Restricted Stock Units (Option Exercise/Conversion)
15 Jan 2020	Form 4/A: Vessey Rupert, Pres., Research & Early Dev. Received 16,060 shares by exercise or conversion · Gave up 7,910 shares to cover exercise price or tax ($508K)
03 Jan 2020	Form 4/A: Vessey Rupert, Pres., Research & Early Dev. Granted 86,955 Restricted Stock Units
03 Jan 2020	Form 4/A: Elkins David V, EVP, Chief Financial Officer Granted 80,398 Restricted Stock Units
03 Jan 2020	Form 4/A: Ahmed Nadim, President, Hematology Granted 48,129 Restricted Stock Units
27 Nov 2019	Form 4/A: Haller Julia A, Director Received 2,409 shares as a grant or award · Granted 83,469 Option (right to buy) · Granted 11,210 Restricted Stock Units
27 Nov 2019	Form 4/A: Bonney Michael W, Director Received 6,069 shares as a grant or award · Granted 102,169 Option (right to buy) · Granted 11,210 Restricted Stock Units
06 May 2019	Form 4/A: Biondi Paul, SVP, Head of Strategy & BD Received 592 shares by exercise or conversion · Gave up 292 shares to cover exercise price or tax ($18.3K)
13 Feb 2019	Form 4/A: Paliwal Dinesh C, Director Bought 9,540 shares ($500K)
31 Jan 2019	Form 4/A: Bancroft Charles A, EVP & Chief Financial Officer Received 6,401 shares by exercise or conversion · Gave up 2,716 shares to cover exercise price or tax ($145K)
06 Dec 2016	Form 4/A: Bancroft Charles A, EVP & Chief Financial Officer Received 6,403 shares by exercise or conversion · Gave up 2,883 shares to cover exercise price or tax ($161K)
23 Mar 2016	Form 4/A: Bancroft Charles A, EVP & Chief Financial Officer Received 75,618.344 shares by exercise or conversion · Acquired 5,378 shares (Other Transaction) · Gave up 36,427 shares to cover exercise price or tax ($2.37M) · 4 more
16 Mar 2016	Form 4/A: Caforio Giovanni, Director Granted 151,666.225 Performance Shares
23 Mar 2015	Form 4/A: Bancroft Charles A, EVP & Chief Financial Officer Received 13,239 shares by exercise or conversion · Acquired 4,781 shares (Other Transaction) · Gave up 8,113 shares to cover exercise price or tax ($532K)
23 Mar 2015	Form 4/A: Andreotti Lamberto, Director Received 48,850 shares by exercise or conversion · Acquired 19,740 shares (Other Transaction) · Gave up 38,295 shares to cover exercise price or tax ($2.51M)
06 Oct 2014	Form 4/A: Paliwal Dinesh C, Director Granted 272.79 Deferred Share Units ($14.1K)
02 Jul 2014	Form 4/A: Paliwal Dinesh C, Director Granted 234.38 Deferred Share Units ($12.2K)
29 Dec 2011	Form 4/A: Leung Sandra, SVP and General Counsel Exercised 3,400 Restricted Stock Units
29 Dec 2011	Form 4/A: Sigal Elliot, EVP, CSO & President R&D Exercised 6,875 Restricted Stock Units

Comments